BAMLANIVIMAB\ETESEVIMAB vs BASILIXIMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BAMLANIVIMAB\ETESEVIMAB vs BASILIXIMAB: Safety Overview
| Metric | BAMLANIVIMAB\ETESEVIMAB | BASILIXIMAB |
|---|---|---|
| Total FAERS Reports | 830 | 6,817 |
| Deaths Reported | 17 | 1,507 |
| Death Rate | 2.0% | 22.1% |
| Hospitalizations | 189 | 2,802 |
| Average Patient Age | 51.3 yrs | 44.2 yrs |
| % Female Patients | 58.5% | 35.9% |
| Manufacturer | N/A | Novartis Pharmaceuticals Corporation |
| Route | N/A | INTRAVENOUS |
| Marketing Status | N/A | Prescription |